Bioinformatics Market to Reach $31.71 Billion by 2031, Driven by Growing Research Activities in Genomics and Rising Need to Develop Novel Drugs/Drug Molecules - Exclusive Report by Meticul...
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Yahoo! Finance
Analysis by Solution & Service (Knowledge Management, Sequence Analysis, Data Analysis), Application (Genomics, Metabolomics, Transcriptomics), Industry (Health, Agriculture)—Global Forecast to 2031. THE BIOINFORMATICS MARKET IS PROJECTED TO REACH $31.71 BILLION BY 2031, AT A CAGR OF 13.4% FROM 2024 TO 2031 Download FREE PDF Brochure Of Bioinformatics Market:- https://www.meticulousresearch.com/download-sample-report/cp_id=5731 The growth of the biotechnology & pharmaceutical industries, initiatives supporting genomics research, and the rising need to develop novel drugs/drug molecules are key factors driving the growth of the bioinformatics market. However, the interoperability limitations of bioinformatics analytical platforms due to multiple data types restrain the growth of this market. Furthermore, emerging economies, the growing clinical applications of genomic technologies, and the increasing use of bioinformatics in agriculture are expected to generate growth opportuni
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis [Yahoo! Finance]Yahoo! Finance
- Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculturePR Newswire
- China's Failing US Lobby Playbook Puts Tech Companies at Risk [Yahoo! Finance Canada]Yahoo! Finance Canada
- FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer [Yahoo! Finance]Yahoo! Finance
- ITRM Posts Updates From FDA Advisory Meeting for UTI Drug, Stock Down [Yahoo! Finance]Yahoo! Finance
ILMN
Earnings
- 8/6/24 - Beat
ILMN
Sec Filings
- 9/17/24 - Form 4
- 9/9/24 - Form 4
- 9/9/24 - Form 8-K
- ILMN's page on the SEC website